New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Inari Medical, Inc.
NARI
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Medical - Devices

Next Earning date - 06 Nov 2024

2B

Medical - Devices

Next Earning date - 06 Nov 2024

42.82USD
Shape2.19 ( 5.39%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 3, 2024
1W 3.93 % 1M -0.60 % 3M -16.68 % 1Y -35.13 %

Key Metrics

Shape
  • Market Cap

    2.49B


  • Shares Outstanding

    58.27M


  • Share in Float

    49.78M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    42.82


  • Average Volume

    895052


  • Beta

    1.004


  • Range

    36.73-69.4


  • Industry

    Medical - Devices


  • Website

    https://www.inarimedical.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.51x

P/S Ratio

5.81x

P/B Ratio

0.1

Debt/Equity

-10.4%

Net Margin

$-1.0

EPS

How NARI compares to sector?

P/E Ratio

Relative Strength

Shape

NARI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$707M

Shape385%

2025-Revenue

$0.07

Shape88%

2025-EPS

$23M

Shape308%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Deutsche Bank

initialise

Previous: Not converted

2024-08-09

Now: Buy

Needham

downgrade

Previous: Not converted

2024-07-18

Now: Hold

Piper Sandler

initialise

Previous: Not converted

2022-06-21

Now: Overweight

Zacks Investment Research

downgrade

Previous: Not converted

2022-04-26

Now: Strong Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.19
vs -0.06

Q4.22

arrow
arrow

N/A

-0.11
vs 0.02

Q1.23

arrow
arrow

N/A

-0.04
vs -0.06

Q2.23

arrow
arrow

+121%

0.04
vs -0.19

Q3.23

arrow
arrow

+126%

0.05
vs -0.19

Q4.23

arrow
arrow

+145%

0.05
vs -0.11

Q1.24

arrow
arrow

N/A

-0.26
vs -0.04

Q2.24

arrow
arrow

N/A

-0.41
vs 0.04

Q3.24

arrow
arrow

N/A

-0.11
vs 0.05

Q4.24

arrow
arrow

N/A

-0.07
vs 0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+32%

96.2M  vs 72.9M

Q4.22

arrow
arrow

+30%

107.8M  vs 83.2M

Q1.23

arrow
arrow

+34%

116.2M  vs 86.8M

Q2.23

arrow
arrow

+28%

119M  vs 92.7M

Q3.23

arrow
arrow

+31%

126.4M  vs 96.2M

Q4.23

arrow
arrow

+23%

132.1M  vs 107.8M

Q1.24

arrow
arrow

+23%

143.2M  vs 116.2M

Q2.24

arrow
arrow

+23%

145.8M  vs 119M

Q3.24

arrow
arrow

+19%

150.6M  vs 126.4M

Q4.24

arrow
arrow

+22%

160.5M  vs 132.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.02

Q4.22

arrow
arrow

-1%

-0.01
vs -0.02

Q1.23

arrow
arrow

-1%

-0.01
vs -0.01

Q2.23

arrow
arrow

+0%

0
vs -0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0

Q4.23

arrow
arrow

-1%

-0.01
vs 0.01

Q1.24

arrow
arrow

-5%

-0.05
vs -0.01

Q2.24

arrow
arrow

-7%

-0.07
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

244

244
vs 232

5%

Q4.22

arrow
arrow

252

252
vs 244

3%

Q1.23

arrow
arrow

265

265
vs 252

5%

Q2.23

arrow
arrow

257

257
vs 265

-3%

Q3.23

arrow
arrow

259

259
vs 257

1%

Q4.23

arrow
arrow

260

260
vs 259

0%

Q1.24

arrow
arrow

235

235
vs 260

-10%

Q2.24

arrow
arrow

244

244
vs 235

4%

Earnings Growth

Latest News